These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20190431)

  • 41. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanochemically induced solid state transformations: The case of raloxifene hydrochloride.
    de Oliveira YS; Oliveira AC; Ayala AP
    Eur J Pharm Sci; 2018 Mar; 114():146-154. PubMed ID: 29198613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S; Ghoroi C
    Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA; Obaidat RM
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisolvent precipitation technique: A very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement.
    Sadeghi F; Ashofteh M; Homayouni A; Abbaspour M; Nokhodchi A; Garekani HA
    Colloids Surf B Biointerfaces; 2016 Nov; 147():258-264. PubMed ID: 27518458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
    Zaheer K; Langguth P
    Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of superdisintegrants in oral dissolving formulation of cinitapride tablets.
    Rehman A; Bushra R; Beg AE; Ali H; Zafar F; Ashfaq M; Alam S; Mustapha O; Shafique S
    Pak J Pharm Sci; 2018 Mar; 31(2(Suppl.)):643-650. PubMed ID: 29625936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.
    Kushwaha AK; Vuddanda PR; Karunanidhi P; Singh SK; Singh S
    Biomed Res Int; 2013; 2013():584549. PubMed ID: 24228255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Production of a new platform based on fumed and mesoporous silica nanoparticles for enhanced solubility and oral bioavailability of raloxifene HCl.
    Varshosaz J; Dayani L; Chegini SP; Minaiyan M
    IET Nanobiotechnol; 2019 Jun; 13(4):392-399. PubMed ID: 31171744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of grinding with hydroxypropyl cellulose on the dissolution and particle size of a poorly water-soluble drug.
    Yamada T; Saito N; Imai T; Otagiri M
    Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1311-3. PubMed ID: 10517010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe.
    Rashid R; Kim DW; Yousaf AM; Mustapha O; Fakhar Ud Din ; Park JH; Yong CS; Oh YK; Youn YS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():6147-59. PubMed ID: 26491288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and evaluation of rapidly dissolving buccal films of naftopidil:
    Elagamy HI; Essa EA; Nouh A; El Maghraby GM
    Drug Dev Ind Pharm; 2019 Oct; 45(10):1695-1706. PubMed ID: 31418592
    [No Abstract]   [Full Text] [Related]  

  • 57. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change.
    Oh DH; Park YJ; Kang JH; Yong CS; Choi HG
    Drug Deliv; 2011 Jan; 18(1):46-53. PubMed ID: 20726805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improvement in oral bioavailability and dissolution of tanshinone IIA by preparation of solid dispersions with porous silica.
    Yan HM; Sun E; Cui L; Jia XB; Jin X
    J Pharm Pharmacol; 2015 Sep; 67(9):1207-14. PubMed ID: 25944009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thermal porosity analysis of croscarmellose sodium and sodium starch glycolate by differential scanning calorimetry.
    Faroongsarng D; Peck GE
    AAPS PharmSciTech; 2003 Dec; 4(4):E67. PubMed ID: 15198562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.